Ex-Officio Members of the Advisory Committee on Breast Cancer in Young Women

Agency for Healthcare Research and Quality

Camille Fabiyi, PhD, MPH

Dr. Camille Fabiyi is the Senior Advisor for Women’s Health and Gender Research within the Office of Extramural Research, Education, and Priority Populations at the Agency for Healthcare Research and Quality (AHRQ). In this role, she conducts, supports, and oversees research on women’s health, perinatal health, and health disparities in the context of health care system quality and improvement and patient safety. She also provides leadership and represents AHRQ on all matters related to women’s health and gender research issues. Prior to joining AHRQ, she served as a senior researcher in the Department of Obstetrics and Gynecology at the University of Chicago, where she conducted reproductive health research. Formerly, she served as the project director on federally funded research projects in the areas of maternal and child health and aging at the University of Illinois at Chicago. Dr. Fabiyi received her PhD in Community Health Sciences with a concentration in Maternal and Child Health and her MPH in Health Policy and Administration at the University of Illinois at Chicago School of Public Health.

Department of Health and Human Services Office on Women’s Health


Health Resources and Services Administration

Nancy Mautone-Smith, MSW, LCSW

Ms. Nancy Mautone-Smith is the Director of the Health Resources and Services Administration (HRSA) Office of Women’s Health. In this role, she leads cross-agency initiatives and consultations to advance the health, safety, and well-being of women served by HRSA programs. She oversees activities and initiatives that support the prevention of intimate partner and interpersonal violence, care coordination for women with opioid use disorder, and advancing cervical health within HRSA settings of care. Ms. Smith previously served as the deputy director of the Office of Women’s Health from 2016 to 2020. Prior to coming to HRSA, she served at the U.S. Department of Health and Human Services Office of Population Affairs Headquarters in Rockville, Maryland, where she led service delivery program activities of the Title X family planning program. She also worked at the Region 9 Office of the Regional Health Administrator, where she oversaw Title X family planning programs throughout the region. In particular, she enjoyed developing and bringing in-person training and technical assistance to award recipients in the Pacific Region, including Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Micronesia, the Republic of Palau, and the Republic of the Marshall Islands. A graduate of the University at Buffalo School of Social Work, Ms. Smith received the 2015 Distinguished Alumni Award for her noteworthy contributions to the social work profession. She retired from the U.S. Public Health Service in 2020 after a career spanning 20 years. Ms. Smith is also a proud Air Force veteran and served as a clinical social worker within mental health and family maltreatment programs at Travis Air Force Base and Vandenberg Air Force Base in California.

Indian Health Service


National Institutes of Health

Jung-Min Lee, MD

Dr. Jung-Min Lee is the Assistant Clinical Investigator in the Women’s Malignancies Branch of the National Cancer Institute. Dr. Lee is a graduate of Yonsei University, Wonju College of Medicine in South Korea. She completed residency training in internal medicine at the Albert Einstein Medical College, followed by a clinical research fellowship on breast cancer functional imaging at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Lee came to the National Cancer Institute for medical oncology training in the Medical Oncology Branch. Subsequently, she joined the Molecular Signaling Section/Women’s Cancers Clinic to investigate potential biomarkers and develop rational combinations of targeted therapies for rare subsets of women’s cancers. Dr. Lee maintains her clinical focus in the development of early clinical trials for ovarian cancer and rare subsets of women’s cancers, such as BRCA1/2 mutation carriers with ovarian and/or breast cancers, or women with triple-negative breast cancer. Dr. Lee is a member of the Gynecologic Oncology Group, American Association for Cancer Research, American Society for Clinical Oncology, and the Breast and Gynecologic Malignancies Faculty of the National Cancer Institute’s Center for Cancer Research.

Page last reviewed: October 28, 2021